Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William T Barry

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Annals of Surgical Oncology|June 22, 2019
Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant ChemotherapyAlison Laws, Melissa E Hughes, Jiani Hu, et al.
Breast Cancer Research and Treatment|September 22, 2019
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastasesJosé Pablo Leone, Dan G Duda, Jiani Hu, et al.
Journal of Geriatric Oncology|January 30, 2014
A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901Jeanne S Mandelblatt, Solomon B Makgoeng, Gheorghe Luta, et al.
Breast Cancer Research and Treatment|June 9, 2016
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysisAntonio Di Meglio, Rachel A Freedman, Nancy U Lin, et al.
BMC Medical Genomics|July 13, 2011
A methodology for utilization of predictive genomic signatures in FFPE samplesJennifer A Freedman, Christina K Augustine, Angelica M Selim, et al.
Clinical Breast Cancer|June 26, 2019
Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 TrialShom Goel, Sonia Pernas, Zhenying Tan-Wasielewski, et al.
Journal of Cancer Survivorship : Research and Practice|June 12, 2014
Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901Leigh Anne Faul, Gheorghe Luta, Vanessa Sheppard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcomeWilliam T Barry, Dawn N Kernagis, Holly K Dressman, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|June 22, 2019
Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant ChemotherapyAlison Laws, Melissa E Hughes, Jiani Hu, et al.
Breast Cancer Research and Treatment|September 22, 2019
A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastasesJosé Pablo Leone, Dan G Duda, Jiani Hu, et al.
Journal of Geriatric Oncology|January 30, 2014
A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901Jeanne S Mandelblatt, Solomon B Makgoeng, Gheorghe Luta, et al.
Breast Cancer Research and Treatment|June 9, 2016
Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysisAntonio Di Meglio, Rachel A Freedman, Nancy U Lin, et al.
BMC Medical Genomics|July 13, 2011
A methodology for utilization of predictive genomic signatures in FFPE samplesJennifer A Freedman, Christina K Augustine, Angelica M Selim, et al.
Clinical Breast Cancer|June 26, 2019
Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 TrialShom Goel, Sonia Pernas, Zhenying Tan-Wasielewski, et al.
Journal of Cancer Survivorship : Research and Practice|June 12, 2014
Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901Leigh Anne Faul, Gheorghe Luta, Vanessa Sheppard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)Hope S Rugo, William T Barry, Alvaro Moreno-Aspitia, et al.
Journal of the National Cancer Institute|September 21, 2010
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerXinhui Wang, Takuya Osada, Yangyang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcomeWilliam T Barry, Dawn N Kernagis, Holly K Dressman, et al.
Pageof 13